Hi, what are you looking for?
Jewish Business News
Search results for "perrigo"
Business
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...
empty
Bolt-on acqusition strengthens position in Europe amid three-way takeover battle with Mylan and Teva
Business
Perrigo Company (NYSE:PRGO; TASE:PRGO) CEO Joseph Papa is ready to talk with Mylan N.V. (MYL) about its takeover bid, but at a higher price....
Business
Deal to give Perrigo manufacturing technology for softgel products
Business
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
Business
Teva declined the chance because it does not operate in the store-brand OTC market, Perrigo's main activity.
Business
When Mylan and Perrigo executives had a “very preliminary” discussion a year ago about possibly merging the two generic drug companies, Perrigo was a...
World News
Mylan offered Perrigo shareholders $75 plus 2.3 Mylan shares per Perrigo share, for a total of $35.6 billion. Perrigo Company (NYSE:PRGO; TASE:PRGO) board of...
World News
Mylan, itself the subject of a hostile takeover bid from Teva, is raising its offer for Perrigo for the second time. Mylan N.V. has...